Differentiated service delivery for TB treatment
The International Journal of Tuberculosis and Lung Disease · 2026
DOI: 10.5588/ijtld.25.0164 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, 2026. Verfasst von H B Mulenga und 18 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Infectious Disease Research in Zambia, Lusaka, Zambia. Hauptthemen laut MEDLINE: Antitubercular Agents, Tuberculosis, Delivery of Health Care, Tuberculosis, Pulmonary. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.
Abstract (Originalsprache)
BACKGROUND
Differentiated service delivery (DSD) includes service decentralisation, multi-month medication dispensing, and treatment support. We describe demographic and clinical characteristics, treatment support, and outcomes among clients treated under a TB treatment DSD model in five facilities in Lusaka and Livingstone, Zambia, from February 2022 to March 2023.
METHODS
Medicines were dispensed for 2 months in intensive and 4 months in the continuation phases of TB treatment. Treatment support was provided through text message, phone, and home visits to monitor symptoms, adherence, and adverse events. Association between demographic, clinical, and treatment support variables and likelihood of successful treatment was examined using Pearson’s χ² or Fisher’s exact tests.
RESULTS
Among 970 clients treated under DSD, most were HIV-negative (72%) and had pulmonary TB (94%). Only 6% of the clients ever-responded to text-based surveys, while 85% were reached by phone or home visit. Overall, 83% of the clients were successfully treated for TB. Significant differences in treatment success were observed by facility (74%–91%, P < 0.001), form of TB (extra-pulmonary 72%, pulmonary 84%, P = 0.020), and received any treatment support (no, 76%, yes, 85%, P = 0.006).
CONCLUSION
DSD models including treatment support may give clients more control over how, when, and where they receive care while achieving treatment success.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
- Division of Global HIV and TB, Global TB Branch, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
- Division of Global HIV and TB, US Centers for Disease Control and Prevention, Lusaka, Zambia.
- National TB and Leprosy Program, Ministry of Health, Lusaka, Zambia.
- Centre for Infectious Disease Research in Zambia, Lusaka, Zambia;, Department of Biostatistics, School of Public Health, University of Ghana, Accra, Ghana.
- Southern Provincial Health Office, Choma, Zambia.
Förderung
- Intramural CDC HHS
Zitieren
APA
Mulenga, H. B., Moore, B. K., Lyembele, C., Kalunkumya, E., Sinkala, T., Mwiinga, L., Lungu, P., Harris, J. B., Bosomprah, S., Banda, C., Nkwemu, C., Mwanza, M. W., Savory, T., Moore, C. B., Mubanga, A., Chiyenu, K., Bweupe, N., Chiyala, M., & Zachary, D. (2026). Differentiated service delivery for TB treatment. The International Journal of Tuberculosis and Lung Disease. https://doi.org/10.5588/ijtld.25.0164
Vancouver
Mulenga HB, Moore BK, Lyembele C, Kalunkumya E, Sinkala T, Mwiinga L, et al. Differentiated service delivery for TB treatment. The International Journal of Tuberculosis and Lung Disease. 2026. doi:10.5588/ijtld.25.0164
BibTeX
@article{Mulenga2026,
author = {Mulenga, H B and Moore, B K and Lyembele, C and Kalunkumya, E and Sinkala, T and Mwiinga, L and Lungu, P and Harris, J B and Bosomprah, S and Banda, C and Nkwemu, C and Mwanza, M W and Savory, T and Moore, C B and Mubanga, A and Chiyenu, K and Bweupe, N and Chiyala, M and Zachary, D},
title = {Differentiated service delivery for TB treatment},
journal = {The International Journal of Tuberculosis and Lung Disease},
year = {2026},
doi = {10.5588/ijtld.25.0164}
}
EUVIMED